Clinical Trials
9 trialsNCT04287075 2024-03-26
Rethink Pain
Axogen Corporation
Terminated
NCT00869804 2023-12-05
HOPE
University of Nebraska
Phase NA Terminated
NCT04034355 2022-01-26
POLAR-A
Egetis Therapeutics
Phase 3 Terminated
NCT04558034 2021-03-08
The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer
Parkview Health
Phase NA Terminated
NCT01783522 2019-10-22
Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT01243541 2019-08-20
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel
Northwestern University
Phase NA Terminated
NCT02795572 2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2 Terminated
NCT03206216 2018-12-19
Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN
Stanford University
Phase NA Terminated
NCT00267007 2014-06-04
A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 2 Terminated